Skip to main content
. 2018 May 3;13(5):e0196858. doi: 10.1371/journal.pone.0196858

Fig 6. Effect of therapy with somatostatin analogues (SSAs) on the plasma levels of total-CgA and VS-1 in patients with ileal and pancreatic NENs.

Fig 6

(A, B) Plasma levels of total-CgA and VS-1 in NENs cases (ileal plus pancreatic NENs) before and after the administration of octreotide LAR. ** (p < 0.01), by Wilcoxon signed-rank test. (C) Correlation between the decrease (%) of the plasma levels of VS-1 and total-CgA after therapy.